The pharma industry’s growth prospects look promising thanks to favorable government initiatives, rising healthcare expenditures, the growing need for quality healthcare and personalized treatments, and the rise in lifestyle-related diseases.
Amid this backdrop, investors could consider diversifying their portfolios by buying fundamentally strong pharma stocks such as Elanco Animal Health Incorporated (ELAN), Viatris Inc. (VTRS), and Astellas Pharma Inc. (ALPMY). These stocks are top-rated in our proprietary POWR Ratings system.
